Skip to main content
Toggle navigation
Login
Search
Home
Preview Program
Browse by Poster Title
Home
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
A
42
A Case of Baclofen-Managed Phenibut Dependence With Concurrent Opioid Use Disorder
Favorite
48
Accelerating Access: A Rapid Methadone Protocol for Outpatient Care
Favorite
187
Access to Urban Setting AA Meetings Reflects Income, Race, and Educational Disparities
Favorite
176
Accuracy of Urine Drug Screen for Substances Other Than Opioids in Pregnancy
Favorite
113
Addiction Medicine Consultation for Patients at Post-Acute Long-Term Care Facilities
Favorite
52
Addiction Treatment Program Quality Measures: Results of a NIDA-Funded Study
Favorite
13
Addiction-Informed Opioid-Sparing Pain Care in the ED: ED-ALT Outcomes
Favorite
162
Adult Cannabis Usage Pattern in a Rural Ohio Community
Favorite
37
Advancing Access to Long-Acting Injectable Buprenorphine Through Community Pharmacies
Favorite
75
Advancing Clinician-Informed, Symptom-Specific Approaches to Opioid Withdrawal Care
Favorite
32
AI-Standardized Patient Reveals Practice Gaps After REMS-Aligned OUD Training
Favorite
145
Alcohol Screening During Surgical Hospitalization Expands Opportunity for Addiction Care
Favorite
84
An Educational Intervention to Improve Trainee Confidence in Managing Opioid Withdrawal
Favorite
31
An Open Label Pilot RCT of Low- vs High-Dose Telemedicine Buprenorphine Initiation
Favorite
35
Assessing the Effects of Sublingual Buprenorphine on Dental Caries
Favorite
108
Associations Between Remission from Opioid Use Disorder and Treatment-Relevant Outcomes
Favorite
135
Auditing Documentation Language in OUD Admissions Using Privacy-Preserving Local LLMs
Favorite
B
30
Barriers Persist: MOUD Knowledge, Attitudes, & Prescribing in North Carolina Family Medicine
Favorite
123
Barriers to Inpatient Use of Opioid-Agonist Therapies
Favorite
95
Behavioral Addictions Might Be More Common and Harmful Than Previously Thought
Favorite
184
BRAIN GAS: B12 Reduction and Ataxia From Inhaled Nitrous Oxide
Favorite
171
Bridging Care: Patient Navigation and Support Team Within an Addiction Consult Service
Favorite
76
Bridging the Divide: A Telemedicine Bridge Clinic Improves Access to OUD Care
Favorite
25
Buh-Bylazine! Xylazine Positivity Rate Change Among Patients in a Low-Barrier Access Clinic
Favorite
29
Buprenorphine Dose and Pain Outcomes in Opioid Use Disorder and Chronic Pain
Favorite
112
Buy-In Without a Blueprint: ED Buprenorphine Initiation in Puerto Rico
Favorite
C
126
Care Barriers & Health Complaints: People Who Inject Drugs in San Antonio
Favorite
33
Characteristics of Pregnant Individuals Receiving Long-Acting Injectable Buprenorphine
Favorite
127
Characterizing Quality of Life for People Who Use Drugs
Favorite
104
Child Custody Loss and Prenatal Engagement in Pregnant Women With Substance Use
Favorite
119
Closing the Gap: Inpatient Methadone and Telehealth OTP Enrollment
Favorite
159
College Shouldn't be a Relapse Risk: National Evidence on Collegiate Recovery
Favorite
38
Co-Located Bridge Clinic/Withdrawal Management Unit Reduces 30-Day Readmits Using LA-Bup Injections
Favorite
62
Comorbidities and Mortality in Substance Use Disorder Patients With Nicotine Dependence
Favorite
99
Comparing Postpartum MOUD Monitoring Across Integrated vs Separate Prenatal Care Models
Favorite
137
Concurrent Mental Illness in a Fentanyl Cohort: Treatment Gaps and Overdose/Suicide Risks
Favorite
57
Confluence of Discrimination and Belongingness in LGBTQ+ Substance Use
Favorite
150
Consequences of GLP-1 Coverage Loss in Alcohol Use Disorder
Favorite
69
Contingency Management in Community Primary Care: An Essential and Successful Integration
Favorite
167
Creative Arts Groups Promote Connection and Flourishing in SUD Recovery
Favorite
54
Current Practice Patterns for Treating Alcohol Use Disorder in US Emergency Departments
Favorite
D
58
Denied at the Door: Accessibility of Substance Use Treatment Facilities
Favorite
156
Designing a Contingency Management App to Support Opioid Agonist Therapy
Favorite
9
Determinants of Naloxone Favorability and Carrying in the General Public
Favorite
59
Disability Rights Training for Peer Support Specialists: A Prospective Survey Study
Favorite
79
Disparities in Adolescent Cannabis Treatment Admissions by the Criminal Justice System
Favorite
158
Distinct Depression-Craving Trajectories During Naltrexone Treatment for Cocaine Use
Favorite
101
Does Neighborhood Disadvantage Affect Pregnant Patients With Opioid Use Disorder?
Favorite
132
Drivers and Deterrents of Accessing Care for Patients With Xylazine-Associated Wounds
Favorite
E
114
Early Uptake and Utilization Patterns of Long-Acting Injectable Buprenorphine
Favorite
164
Educational Attainment Levels Shape Substance Use, Disorder Risk, and Care Access
Favorite
51
Effectiveness and Key Components of Recovery Communities: A Rapid Review
Favorite
100
EHR Affects Stigma Manifestations and Care Decisions by Peripartum Women With SUD
Favorite
5
EMS-Attended Overdoses Before and After the COVID-19 Pandemic in Camden, New Jersey
Favorite
182
Evidence for Safety and Tolerability of Transcranial Magnetic Stimulation for SUD
Favorite
157
Examining National Harm Reduction and Impact on Implementation of Contingency Management
Favorite
121
Expanding Access: Empowering Recovery Through Self-Administered Methadone
Favorite
56
Expanding Screening and Treatment for Alcohol Use Disorder for Undocumented Latinx Patients
Favorite
15
Extracting Post-Opioid Overdose Care from ED Encounters Using Large Language Models
Favorite
F
125
Feasibility of Addiction CaRE: A Program Supporting Hospitalized Patients With SUD
Favorite
170
From Crisis to Connection: Insights From the THRIVE Peer Recovery Program
Favorite
G
111
GLP-1 Receptor Agonists Improve Outcomes in Patients Receiving Buprenorphine for OUD
Favorite
H
86
Health Claims and Marketing Practices in the Online Kratom Marketplace
Favorite
147
Hepatic Failure as an Obstacle in Treating Alcohol Withdrawal and Serotonin Toxicity
Favorite
71
High Completion and Patient Satisfaction in a Virtual Ambulatory Alcohol Detox Program
Favorite
39
High Retention Over 24 Months in Telehealth-Only Buprenorphine Program
Favorite
115
Higher Buprenorphine Doses Improve Treatment Engagement and Outcomes in Opioid Use Disorder
Favorite
3
HIV/PrEP Knowledge, Perceived Risk, and Attitudes Among PWID After a Hospital Intervention
Favorite
153
Hospital Alcohol Withdrawal Protocol: Improving Outcomes and Reducing Length of Stay
Favorite
36
Human Laboratory Evaluation of Direct-to-Inject XR-Buprenorphine: Preliminary Results
Favorite
I
67
Impact of Contingency Management on Retention in Outpatient SUD Programs
Favorite
23
Impact of Implementation Strategies on Collaboration Between Drug Courts and MOUD Providers
Favorite
24
Impact of MOUD on Mental Health and Counseling Services in Jails
Favorite
53
Impact of OAT in Individuals With OUD Who Experienced Overdose in Ontario
Favorite
168
Impact of Resource Linkage on Rehospitalization in People With Substance Use Disorders
Favorite
117
Implementing Harm Reduction in a Binational Context: Key Informant Perspectives
Favorite
107
Inadequate Pharmacy Stocking of Buprenorphine in Washington, DC: A Cross-Sectional Survey
Favorite
77
Increased Healthcare Utilization and Acuity Associated With Medetomidine
Favorite
55
Increased Naltrexone Prescribed for Alcohol Use After Changes to Obesity Treatment Protocol
Favorite
131
Increased Social Support May Provide a Protective Effect Against Recurrent Drug Overdoses
Favorite
44
Initiating Methadone for the Incarcerated: Implementation at Allegheny County Jail
Favorite
109
Injectable OUD Medications via Telehealth Providers and Local Pharmacies
Favorite
28
Inpatient Discharge Prescribing and Early Engagement Predict Buprenorphine Continuation
Favorite
181
Inpatient Order Set Increases Initiation of Medications for Substance Use Disorders
Favorite
174
Intensive Community Care Reduces Over-Utilization of Healthcare Resources
Favorite
151
Interactions of Gender Identity and Social Factors in Unhealthy Alcohol Use
Favorite
139
Investigating Mediators Between Antecedent Childhood Trauma and Drug Overdose Among Adults
Favorite
K
72
Ketamine Effects on Anxiety and Drug Seeking Behaviors in Methamphetamine-Withdrawn Rats
Favorite
70
Ketamine for Co-Cccurring Major Depressive and Alcohol Use Disorders: A Systematic Review
Favorite
41
Kratom Use in ADHD: A Case Highlighting Stimulant and Injectable-Buprenorphine Initiation
Favorite
L
97
Lift Me Up or Bring Me Down: Partner Influence on Substance Use
Favorite
169
Live One, Do One, Teach One: Building Recovery Support Services Workforce Capacity
Favorite
64
Local Policy Matters: Structural Violence, Vaping, and Immigrant-Inclusive Protections
Favorite
M
134
Mapping Non-Fatal Overdoses in Palm Beach County: Spatial Risk Analysis
Favorite
140
Mapping Psychosocial Pathways From Trauma to Substance Use Risk in Immigrant Adolescents
Favorite
19
Maternal and Fetal Effects Associated With Perinatal Xylazine Exposure: A Systematic Review
Favorite
143
Meta-Analysis of Ketamine’s Effects on Craving and Abstinence in Substance Use Disorders
Favorite
20
Methadone as Treatment for Tianeptine Withdrawal
Favorite
66
Mixed-Methods Contingency Management for Smoking in Perinatal Opioid Use Disorder
Favorite
68
Mobilizing Contingency Management for Stimulant Use Disorder in the Street Medicine Setting
Favorite
120
Modeling the Effects of Global Opioid Treatment Recommendations on US Methadone and Buprenorphine Access
Favorite
96
Mothers in Addiction Treatment: Demographic and Clinical Trends from 2005 to 2025
Favorite
160
Motivation for Change and Treatment Among Transition-Age Adults With Substance Use Disorder
Favorite
N
163
Naloxone Training Improves Medical Students’ Knowledge and Attitudes: A Two-Year Survey
Favorite
8
Naloxone Vending at Jail Release Works Without Mandatory Overdose Education
Favorite
142
Naltrexone Treatment for AI Chatbot Addiction in Adolescent With ASD and ADHD
Favorite
61
New Extremely High Urine Cotinine Levels in Adolescents Who Vape Nicotine
Favorite
183
Nitrous Oxide Induced Myelopathy With Acute Urinary Retention and Pulmonary Embolism
Favorite
63
No Better Time Than the Present: Helping Hospitalized Veterans Quit Smoking
Favorite
180
No Colon Left Behind: Increasing Colorectal Cancer Screening Rates Among SUD Patients
Favorite
O
155
One Measure, Two Stories: How AUDIT vs. AUDIT-C Shape SBIRT Implementation
Favorite
90
Opioid Management Review Committee Enhances Addiction Competencies in Palliative Care
Favorite
136
Opioid Treatment Engagement and Retention: A Risk and Protective Factor Examination
Favorite
34
Opioid Use Disorder Treatment Model: Access to Healthcare Barrier Survey
Favorite
118
Opioid-Stimulant Injecting and Smoking: Multilevel Influences in San Diego-Tijuana
Favorite
14
OPRD1 rs678849 Predicts Buprenorphine Outcomes in an ED-Initiated MOUD Program
Favorite
4
Optimizing Geographic Naloxone Distribution to Reduce Opioid Overdose Deaths
Favorite
179
Outcomes for Patients With Substance Use History Evaluated for Advanced Cardiac Therapies
Favorite
26
Overcoming Barriers to Outpatient Buprenorphine Treatment for Opioid Use Disorder
Favorite
P
89
Participant Perspectives of a Peer Recovery-Enhanced Jail MAT Program
Favorite
172
Paths to Recovery: An Integrated, Rapid-Access Model for Outpatient Addiction Care
Favorite
49
Patient Experiences With a Low-Threshold Mobile Medical Unit for Opioid Use Disorder
Favorite
116
Patient Outcomes After Field-Initiated Buprenorphine With and Without ED Transport
Favorite
10
Patient-Centered Design: Improving Naloxone Access Through Patient Insights
Favorite
141
Patient-Provider Relationship Quality in Teens at Risk for Substance Use
Favorite
173
Patients With Opioid Use Disorder Report Compassionate Care but Missed Support Opportunity
Favorite
6
Perceptions of Harm Reduction Integration in Treatment: A Qualitative Study
Favorite
27
Perceptions of Psilocybin Assisted Therapy (PAT) for Substance Use Disorder
Favorite
128
Perspectives from People Who Use Drugs: Experiences Using Fentanyl Containing BTMPS
Favorite
83
Polysubstance Use Among New York Transition-Age Adults Who Use Opioids, 2018–2024
Favorite
177
Predictors of Engagement in a Remote Tobacco Cessation Randomized Trial
Favorite
178
Predictors of Success in an Intensive, Online Smoking Cessation Program (MINDonline)
Favorite
11
Pre-EMS Naloxone Administrator Role and Predictors of Receiving Subsequent Naloxone by EMS
Favorite
73
Prenatal Methamphetamine Exposure and Intracranial Hemorrhage in Infants
Favorite
2
PrEP Eligibility Among People Who Use Drugs Accessing Opioid Treatment Programs
Favorite
165
Provider Education and Patient Screening for In-Hospital Substance Use: A QI Project
Favorite
175
Provider Perspectives and Understanding of Urine Drug Screening
Favorite
146
Provider-Reported Barriers to Screening and Treating Alcohol Use Disorder
Favorite
Q
46
QTc Prolongation of Slow-Release Oral Morphine vs Methadone for Opioid Use Disorder
Favorite
R
45
Rapid Methadone Titration Protocols in Opioid Use Disorder: A Systematic Review
Favorite
12
Real-World Analysis of Buprenorphine-Precipitated Opioid Withdrawal: A Multicenter Study
Favorite
50
Real-World Healthcare Utilization With SROM Versus Methadone: A Target Trial Emulation
Favorite
130
Recovery Housing Without Abstinence Requirements: Outcomes of a Low-Threshold Pilot
Favorite
22
Recovery is WORTH IT: Data from a Statewide Low-Threshold Buprenorphine Telehealth Program
Favorite
129
Recurrent Overdose Survival Modeling for Smarter Harm Reduction Deployment
Favorite
166
Reddit Discussions About Stimulant Use and ADHD Symptoms
Favorite
92
Reducing Hospital Costs and Improving Access to Care With Hotel Vouchers
Favorite
78
Relations Between Cannabis Craving, Distress Intolerance, And Coping Motives: A Pilot Study
Favorite
87
Relationship Conflict Reduces Recovery Capital: Oregon 2SLGBTQIA+ Community Findings
Favorite
105
Revised Drug Screening Restores Equity Without Compromising Neonatal Safety
Favorite
124
Rising Regional Burden of Substance Use Disorders: GBD 2023 Analysis
Favorite
47
Risk Reduction in Methadone Clinics: Addressing the Complexities of Opioid Use Disorder
Favorite
133
Rural-Urban Disparities in Tobacco, Alcohol, and Opioid Co-Use Among US Adults, 2021–2023
Favorite
S
149
Safety of Naltrexone for Alcohol Use Disorder Treatment in Liver Transplant Recipients
Favorite
80
SBIRT Model to Combine Direct Early Intervention and mHealth for Substance-Involved Youth
Favorite
81
Screening, Brief Intervention, and Referral to Treatment Dose Effects in Foster Youth
Favorite
16
Self-Reported Effects Associated With Xylazine/Medetomidine in Drug Checking Samples
Favorite
74
Sensory Processing Sensitivity and Substance Use Disorder: A Multidimensional Exploration
Favorite
122
Social Isolation and Loneliness Among Older Adults With Opioid Use Disorder
Favorite
152
Socioeconomic Status and Unhealthy Alcohol Use Among Transgender Adults
Favorite
102
Start High, Go Fast: Rapid Split-Dose Inpatient Methadone Titration in Pregnancy
Favorite
7
Stigma and Treatment Engagement in Addiction Medicine: Pilot Findings Across Stigma Domains
Favorite
43
Stigma as a Barrier to Early Retention in MOUD Treatment
Favorite
60
Substance Use Among Adolescents in Pediatric Primary Care
Favorite
98
Substance Use Disorders and Fertility Care: Disparities in Evaluation and Treatment
Favorite
40
Successful Buprenorphine Microinduction in Patient With Severe Kratom (7-OH) Use Disorder
Favorite
1
Successful Implementation of HCV Point-of-Care Testing in a Syringe Services Program
Favorite
T
148
Tacrolimus Variability With Cannabis Use After Alcohol-Associated Liver Transplant
Favorite
110
The Effect of Music on Opioid-Related Cue Reactivity
Favorite
138
The Impact of Substance Use on Mental Health Care in Adolescents
Favorite
106
The Promise of Extended-Release Buprenorphine for Opioid Use Disorder
Favorite
82
The Relationship Between Problematic Internet Use and Substance Use in Adolescents
Favorite
21
Tianeptine Misuse: Systematic Review of Clinical Features, Withdrawal, and Management
Favorite
65
Tobacco-Stimulant Co-Use Among US Adults: National Trends and Persistent Role of Tobacco
Favorite
144
Towards Accurate Interpretations of Liver Transplantation Outcomes in Alcohol Use Disorder
Favorite
161
Treating Substance Use Disorder in Interim Housing Settings With Contingency Management
Favorite
85
Treatment First: Early Trends in Use of Opioid Settlement Funds Across USA
Favorite
103
Treatment Recommendations for Benzodiazepine Use in Pregnancy: A Scoping Review
Favorite
185
Trends in Documentation of Stigmatizing Language for Addiction from 2013 to Present
Favorite
W
94
When Hot Flashes Are Not Withdrawal: Perimenopause in Opioid Use Disorder
Favorite
154
When Treatment Turns Toxic: Naltrexone-Induced Psychosis During Alcohol Withdrawal
Favorite
186
Words Do Hurt: Curbing Stigmatizing Words in Substance Use Disorder Treatment
Favorite
93
Words Matter: Results of a Stigma Reduction Initiative in a Safety-Net System
Favorite
91
Written Exposure Therapy for PTSD Increases Recovery Capital for Adults With SUD
Favorite
X
18
Xylazine in the Fentanyl Era: Patient Perspectives on Methadone and Emergency Care
Favorite
17
Xylazine-Adulterated Fentanyl in Pregnancy: Postpartum Withdrawal With GI Hemorrhage
Favorite
